SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?


To: Bill Wexler who wrote (989)12/15/1997 2:49:00 PM
From: Dauntless  Read Replies (1) | Respond to of 7041
 
Re: "I believe that Asensio's target of <5 a share is quite likely."

That would create an interesting situation as the company has more than $6 cash/share.



To: Bill Wexler who wrote (989)12/15/1997 6:12:00 PM
From: Michael Bidder  Respond to of 7041
 
Thanks Bill,

Check out the Gold companies for dead ducks. Royal Oak comes to mind. The promotion posters are suporting it on the net and I asume also through their broker conections. The company is in need of a quick 50 mill to retain ownership of a mine in development. Unfortunatly I do not forsee an underwriting in in gold happening any time soon. Just for yor info. Watch close over the next few months.



To: Bill Wexler who wrote (989)12/15/1997 6:14:00 PM
From: Claud B  Read Replies (1) | Respond to of 7041
 
<One of the things that really startled me about ZONA was the low short interest.>

Is almost 2 million shares short startling to you?
That's almost 20% of the the outstanding shares.

Claud